SPDL1 and non-small cell lung carcinoma: On the other hand, Li et al. [20] demonstrated that the sEVPD-L1 levels were significantly higher in patients with stage III and IV NSCLC than in healthy controls, whereas there was no difference in the levels of sPD-L1.